GHRH Analog
Sort by
Price filter
Peptide Family
Filter by brand
test
CJC-1295 no DAC
CJC-1295 without DAC (also known as Mod GRF 1-29) is a synthetic 30-amino-acid analog of growth hormone-releasing hormone (GHRH), modified at four positions for enhanced enzymatic stability without the Drug Affinity Complex. Extensively studied in preclinical research for its role in pulsatile GH release, typically in combination with GHRP-class peptides. Lyophilized powder, ≥99% purity, third-party tested. For laboratory and research use only — not for human consumption.
CJC-1295 with DAC
CJC-1295 with DAC is a synthetic long-acting analog of growth hormone-releasing hormone (GHRH), modified with a Drug Affinity Complex (DAC) for extended half-life. Extensively studied in preclinical research for its role in sustained GHRH-receptor activation and GH-axis modulation. Lyophilized powder, ≥99% purity, third-party tested. For laboratory and research use only — not for human consumption.
CJC-1295 + Ipamorelin
CJC-1295 + Ipamorelin Combo is a research peptide blend pairing two of the most extensively studied growth hormone secretagogues. CJC-1295, a long-acting GHRH analog, and Ipamorelin, a selective GHRP, have been individually researched for their complementary roles in pulsatile GH release pathways. Lyophilized powder, ≥99% purity per compound, third-party tested. For laboratory and research use only — not for human consumption.
Tesamorelin
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) composed of 44 amino acids with a modified N-terminus for enhanced stability. Extensively studied in preclinical research for its role in GH secretion, body composition, and metabolic pathways. Lyophilized powder, ≥99% purity, third-party tested. For laboratory and research use only — not for human consumption.
GHRH analogs are synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic peptide that stimulates pituitary growth hormone (GH) release. These compounds are studied extensively in pituitary signaling research, GH pulsatility studies, and comparative pharmacology of natural versus modified GHRH structures.
Structural modifications in GHRH analogs alter receptor binding affinity, resistance to enzymatic degradation, and half-life — making this family particularly valuable for studying how modifications to a parent peptide influence downstream biological activity. The Drug Affinity Complex (DAC) modification, for example, dramatically extends circulating half-life, allowing researchers to compare pulsatile versus sustained GHRH signaling models.
GHRH analogs in our catalog include CJC-1295 (with and without DAC), Tesamorelin (a stabilized GHRH analog), and pre-mixed GHRH + GHRP combinations for synergistic signaling research.
Each compound is supplied as a lyophilized powder, ≥98% purity, with Certificate of Analysis. For laboratory research use only.